Relevance of Kidney-Metabolic Multimorbidity Pattern to Metabolic Health and Mortality Among Elderly Inpatients in

Lan Xu1, Mengjing Wang2,3, Guoyou Qin4

  • 1Division of Geriatrics Huashan Hospital, Fudan University Shanghai China.

Insights

Globally aging populations face multimorbidity challenges. The prevalent "Kidney-metabolic" pattern, involving chronic kidney disease (CKD) and metabolic disorders, significantly increases mortality risk in elderly patients, especially with age.

Area of Science:

  • Gerontology
  • Nephrology
  • Metabolic Diseases

Background:

  • Global population aging presents significant multimorbidity challenges.
  • Chronic kidney disease (CKD) is a common aging-related condition with rising mortality.
  • CKD-associated multimorbidity patterns and their impact are underreported.

Purpose of the Study:

  • To investigate the prevalence and patterns of multimorbidity in elderly patients.
  • To specifically analyze CKD-associated multimorbidity patterns.
  • To determine the impact of these patterns on metabolic health and mortality.

Main Methods:

  • Cross-sectional analysis of 163,626 elderly inpatients (≥60 years) from Huashan Hospital, Shanghai (2013-2019).
  • Included 48 chronic diseases; multimorbidity defined as co-occurrence of two or more.
  • Factor analysis identified multimorbidity patterns.

Main Results:

  • The
  • Kidney-metabolic
  • pattern (CKD, hypertension, diabetes, lipid disorders) was most prevalent (13.3%).
  • 80.7% of CKD patients had other comorbidities.
  • All four identified patterns (
  • Kidney-metabolic
  • ,
  • Cerebro-vascular
  • ,
  • Cardio-pulmonary
  • ,
  • Thyroid-digestive
  • ) were associated with increased mortality.
  • The
  • Kidney-metabolic
  • pattern's mortality impact significantly increased with age.

Conclusions:

  • The
  • Kidney-metabolic
  • pattern is the most prevalent multimorbidity pattern in elderly patients.
  • This pattern highlights intertwined metabolic and nutrition-related conditions.
  • It represents predominant combined risk factors impacting metabolic health and mortality in aging populations.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
348
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
674
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
379
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
4